Liwei Meng
No.107 Culture Road
Jinan, 250000, China
Jinan, 250000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Insulin-like growth factor binding protein-3 serves as a biomarker for resistance to enzalutamide in prostate cancer.
Journal: Apoptosis : an international journal on programmed cell death
Published: February 04, 2026
Targeting the HSPA8-CMA-ATP6V1A Axis Triggers Lysosomal Hyperacidification and Catastrophic Vacuolation in Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 08, 2026
Genetic features of TP53 mutation and its downstream FOXA1 in prostate cancer.
Journal: Bioscience trends
Published: June 29, 2022
Case report: An ectopic adrenocortical adenoma in the renal sinus.
Journal: Frontiers in oncology
Published: May 03, 2022
LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
Journal: Cell death & disease
Published: May 19, 2020
Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting FOXO3.
Journal: Aging
Published: March 18, 2020
LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathway.
Journal: Cancer cell international
Published: October 22, 2019
Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 18, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026